Country(s): Austria, Belgium, Canada, Denmark, Estonia, Egypt, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Norway, Poland, Romania, Spain, Sweden, Turkey,

Deadline: 05-03-2020 17:00 CET (pre-proposals)

Deadline:15-06-2020 17:00 CET (full proposals)


ERA PerMed is an ERA-Net Cofund, supported by 32 partners of 23 countries and co-funded by the European Commission (EC). To align national research strategies, promote excellence, reinforce the competitiveness of European players in Personalised Medicine (PM), and enhance the European collaboration with non-EU countries, 31 funding organisations have agreed to launch the third Joint Transnational Call for collaborative innovative research projects in Personalised Medicine (PM).

This represents the second of three potential additional calls not co-funded by the EC. The funding organisations participating in this call particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research proposals.

The overall objectives of the ERA PerMed Call are:

The overall objectives of the call are to:

– Support translational research projects in the field of Personalised Medicine;

– Encourage and enable interdisciplinary collaborations towards the implementation of PM, combining pre-clinical and/or clinical research with bioinformatics components and research on relevant ethical, legal and social aspects and/or research on the optimisation of health care systems;

– Encourage collaboration between academia (research teams from universities, higher education institutions, public research institutions), clinical/public health research (research teams from hospital/ public health, health care settings and other health care organisations), private partners e.g. SMEs1 (small and medium-sized enterprises) as well as policy makers, regulatory/HTA agencies and patient organisations.

Proposals must be interdisciplinary and clearly demonstrate the potential impact in PM as well as the added value of transnational collaboration.


Aims of the call

With its third transnational call (non-cofunded by the EC), ERA PerMed fosters research and innovation activities that build close linkages between basic biomedical research, clinical research, physical sciences, bioengineering, bioinformatics and biostatistics, epidemiology, socio-economic research, as well as research on the integration of PM into clinical practice and on ethical, legal and social implications across the participating countries and beyond.

This implies a wide range of multidisciplinary activities brought together by different Page 2 stakeholders from academia (e.g. universities and research institutions), clinics (e.g. clinical laboratories, medical professionals), industry (e.g. pharmaceutical industry, biotechnology companies, information technology companies including health information technology – HIT), policy makers, regulatory/health technology assessment (HTA) agencies and patients/patient organisations.

The overarching goal is to improve disease prevention and disease management, based on broader and more efficiently characterised and defined patient stratification, diagnostics and tailored treatment protocols. Early involvement of regulatory authorities and close interaction with the different key players along the value chain should be included right from the project development phase to bridge the gap between first discoveries or inventions until market access. Proposals submitted under this call are expected to demonstrate the applicability of project outcomes to clinical practice. The clinical relevance of the proposed
PM approach needs to be convincingly demonstrated. Moreover, proposals are expected to include research on ethical, legal and socio-economic implications, including health economics and regulation, and/or research on the optimisation of health care systems. They may also consider patient and citizen empowerment and training strategies for the different stakeholders in PM.

Scope of the call

Proposals must be interdisciplinary and clearly demonstrate the potential impact in PM as well as the added value of transnational collaboration. The JTC2020 of ERA PerMed will comprise three Research Areas:

Each project proposal MUST address at least one module of Research Area 3 and at least one module of Research Area 1 or 2. The coherent integration and combination of the different Research Areas and Modules in the proposals will be part of the evaluation process.

View full pre-announcement text

If you are looking for potential partners, please have a look at the ICPerMed Partnering Tool

View full pre-announcement Call text on ERA PER MED website


  • The FNR supports this Call with 300,000 EUR.
  • Overall budget for this Call is approx 24 MEUR


In addition to submitting at ERA PerMed, Luxembourg applicants must also submit the proposal – along with the FNR INTER documents – to the FNR no later than 5 working days after the ERA PerMed deadline(s).


  • Opening of online submission tool: December 2019
  • Submission deadline for pre-proposals: March 2020
  • Submission deadline for full-proposals: 15 June 2020
This site uses cookies. By continuing to use this site, you agree to the use of cookies for analytics purposes. Find out more in our Privacy Statement